Aton is dedicated to changing how medicines are researched and developed. Safer therapies, for better outcomes.
Our leading-edge companies, each deploying a specialism, work in synergy in our ecosystem to accelerate and advance the testing and development of effective medicines, to give every patient access to tomorrow’s therapies: the right treatment, to the right person, at the right time.
Founded in 1998, and headquartered in France (Strasbourg), we are a leading bioscience company that helps accelerate safer, more effective medicines for patients around the world.
We have recently re-branded as ‘ATON’ to reflect our company’s new vision and strategy, signalling a new direction for the organization and we are embarking on a number of new and exciting ventures.
Aton foresees a focused future of medicine. We’re driving a fundamental shift to provide more effective testing, to produce safer treatments, adapted to the patient’s biology.
Our determination is forged out of experience. We will succeed in creating the more effective medicines of tomorrow, but we won’t get there using old methodologies.
By harnessing our experience and insights, and through collaborations with leading scientists and institutions, ATON and our portfolio of specialist bioscience companies seek to uncover new insights into disease mechanisms and discover novel therapeutic targets by guiding and supporting life science enterprises.
Diverse businesses, each with unique technologies, experience and skills, but one team, united by one desire — to advance and accelerate the pursuit of tomorrow’s therapies: delivering the right treatment, to the right patient, at the right time.
Aton Lifesciences. Turn research into medicines.
Full & Concrete Support
We actively guide and energize our companies by providing our expertise in all management activities so that they can focus on their core business and reach their full potential.
Cutting Edge Bioscience Platforms
We bring together a growing and complementary portfolio of cutting-edge technologies to create real value in the development of safer and more effective treatments. While working as one team, each of our platforms has its own capabilities and technologies.
Robust & Focused Model
We focus on acquiring companies that can have a proven positive impact on the healthcare sector.
We focus on sourcing, financing, guiding, supporting, and energising bioscience companies, through cutting-edge technologies.
We focus on sourcing, financing, guiding, supporting, and energising bioscience companies, through cutting-edge technologies.
Sourcing & Financing
- We identify timely and optimal opportunities to create real value for our shareholders.
- We conscientiously select technologies that have a real impact on the development of tomorrow’s medicine.
- We create a growing and complementary portfolio of bioscience companies at several stages of the drug development process and in a large range of therapeutic areas.
Guide, Support and Energize
- We take a concrete, hands-on approach ensuring our businesses are successful, including providing support and operational functions.
- We have the experience and the capability to put our shareholders’ needs first and mitigate any potential risks.
OUR PLATFORMS
Game-changing life science platforms
Preclinical & Clinical Services
Preclinical & Clinical Services
Monoclonal Antibodies Production
Monoclonal Antibodies Production
Laboratory Equipment Production
Laboratory Equipment Production
Medical Device Production
Medical Device Production
Human Tissue Provision
Human Tissue Provision
Let’s talk!
Please leave your details and we’ll get back to you.
